Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07192731 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Study on Treatment of Liver (HCC) Patients With IRE

Study acronym: LIVERHCC-IRE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study title shortened, about 14 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Procedural data will be recorded from patients with liver lesions from hepatocellular cancer who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation
Trial Details
NCT Number NCT07192731
Lead Sponsor Angiodynamics, Inc.
Conditions
(from sponsor)		 Hepatocellular Carcinoma (HCC), Liver Ablation, Liver Cancer, Adult
Related terms Carcinoma, Hepatocellular
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov